Targeting cognition in schizophrenia research: from etiology to treatment.
Goldberg
Terry E
TE
Gomar
Jesus J
JJ
D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology*; D003987:Dibenzothiazepines / Q000494:pharmacology / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D013469:Sulpiride / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; C092292:ziprasidone; D013469:Sulpiride; D000077582:Amisulpride; D006220:Haloperidol; D000077152:Olanzapine